R&D News | pharmaphorum

News

Pfizer raises pressure on GSK, J&J with late-stage RSV vacci...

Pfizer has vaulted ahead with its respiratory syncytial virus (RSV) vaccine, closing the gap with GlaxoSmithKline and Johnson & Johnson as the companies strive to bring the first licens

News

J&J vaccine fails to protect women against HIV infection

Johnson & Johnson's HIV vaccine candidate has failed its first major efficacy test, as it was unable to protect women against infection with the virus in a phase 2b trial carried out in

News

'Endless RNA' startup Laronde raises $440m to fuel pipeline

Just a few months after breaking cover with its new take on RNA therapeutics, Laronde has raised an impressive $440 million in second-round financing backed by Flagship Pioneering – which w

News

Data points to big win for Jardiance in hard-to-treat heart ...

The data is now in from the EMPEROR-Preserved study of Boehringer Ingelheim and Eli Lilly's Jardiance in heart failure with preserved ejection fraction (HFpEF), and suggest the drug perform

News

GSK takes SK bio-partnered COVID jab into phase 3

As a top vaccine maker, GlaxoSmithKline has been a laggard in the COVID-19 vaccine race, but has put on a late burst of speed with a start of phase 3 trials of a second candidate that will

News

Concept of memory loss and brain aging due to dementia and alzheimer's disease as a medical icon with fall trees shaped as a human head losing leaves with 3D illustration elements.

AC Immune claims half a win for tau drug in Alzheimer's tria...

Shares in AC Immune leaped today after the company said its tau-targeting Alzheimer's disease candidate semorinemab hit one of its objectives in a phase 2 trial, although it missed another.

Pfizer raises pressure on GSK, J&J with late-stage RSV vacci...

J&J vaccine fails to protect women against HIV infection

'Endless RNA' startup Laronde raises $440m to fuel pipeline

Data points to big win for Jardiance in hard-to-treat heart ...

GSK takes SK bio-partnered COVID jab into phase 3

AC Immune claims half a win for tau drug in Alzheimer's tria...

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks